消融LAT2转运蛋白引起肌内谷氨酰胺积累和抑制空腹诱导的蛋白水解

IF 9.1 1区 医学 Q1 GERIATRICS & GERONTOLOGY
Meritxell Espino-Guarch, Susie Shih Yin Huang, Clara Vilches, Esther Prat, Rana El Nahas, Ghalia Missous, Susanna Bodoy, Abbirami Sathappan, Mohammad Ameen Al-Aghbar, Clara Mayayo, Montse Olivé, Silvia Busquets-Rius, David Sebastián, Antonio Zorzano, Manuel Palacin, Nicholas van Panhuys, Virginia Nunes
{"title":"消融LAT2转运蛋白引起肌内谷氨酰胺积累和抑制空腹诱导的蛋白水解","authors":"Meritxell Espino-Guarch,&nbsp;Susie Shih Yin Huang,&nbsp;Clara Vilches,&nbsp;Esther Prat,&nbsp;Rana El Nahas,&nbsp;Ghalia Missous,&nbsp;Susanna Bodoy,&nbsp;Abbirami Sathappan,&nbsp;Mohammad Ameen Al-Aghbar,&nbsp;Clara Mayayo,&nbsp;Montse Olivé,&nbsp;Silvia Busquets-Rius,&nbsp;David Sebastián,&nbsp;Antonio Zorzano,&nbsp;Manuel Palacin,&nbsp;Nicholas van Panhuys,&nbsp;Virginia Nunes","doi":"10.1002/jcsm.13847","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>The neutral amino acid transporter <i>SLC7A8</i> (LAT2) has been described as a key regulator of metabolic adaptation. LAT2 mutations in human populations have been linked to the early onset of age-related hearing loss and cataract growth. As LAT2 was previously found to be highly expressed in skeletal muscle, here we characterised its role in the regulation of <i>skeletal muscle</i> amino acid flux and metabolic adaptation to fasting.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Wild-type (WT) and LAT2 knock-out (LAT2KO) mice were exposed to short- and long-periods of fasting (16 and 48 h). The impact of the absence of LAT2 on amino acid content, gene expression, proteolysis activity, muscle tone, and histology was measured. To characterise the impact on muscle degradation, we tested LAT2 KO mice in cancer-associated cachexia, streptozocin-induced Type-1 diabetes, and ageing models.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>LAT2KO mice experienced a notable reduction in body weight during fasting (WT:14% and LAT2KO:18%, <i>p</i> = 0.02), with a greater reduction in fat mass (0.5-fold, <i>p</i> = 0.013) and a higher relative retention of muscle mass (1.3-fold, <i>p</i> = 0.0003) compared with WT. The absence of LAT2 led to increased intramuscular glutamine (Gln) accumulation (6.3-fold, <i>p</i> &lt; 0.0001), accompanied by a reduction in skeletal muscle proteolysis during fasting (0.61-fold, <i>p</i> = 0.0004) primarily due to decreased proteasomal and autophagic activity (0.45-fold, <i>p</i> = 0.016 and 0.7-fold, <i>p</i> = 0.002, respectively). Ex vivo incubation of LAT2KO muscle with rapamycin recovered proteolysis function, demonstrating a mTORC1-dependent pathway. Decreased proteolysis in LAT2KO animals was associated with increased mTORC1 translocation to the lysosome (mTORC1-Lamp1 colocalization in fasted LAT2KO muscles was 1.23-fold, <i>p</i> &lt; 0.0001). Of the three muscle loss models tested, differences were observed only during ageing. Young LAT2KO mice (3 M) exhibited muscle tone and MurF1 expression levels comparable to those of older WT mice (12 M) (0.44-fold, <i>p</i> = 0.02 and 0.48-fold, <i>p</i> = 0.04, respectively).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>LAT2 has a critical role in regulating Gln efflux from skeletal muscle. The absence of LAT2 led to elevated intracellular Gln levels, impairing muscle proteolysis by inducing mTORC1 recruitment to the lysosome. Further, chronic Gln accumulation and decreased proteolysis were found to induce the early onset of an age-related muscle phenotype.</p>\n </section>\n </div>","PeriodicalId":48911,"journal":{"name":"Journal of Cachexia Sarcopenia and Muscle","volume":"16 3","pages":""},"PeriodicalIF":9.1000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcsm.13847","citationCount":"0","resultStr":"{\"title\":\"Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting-Induced Proteolysis\",\"authors\":\"Meritxell Espino-Guarch,&nbsp;Susie Shih Yin Huang,&nbsp;Clara Vilches,&nbsp;Esther Prat,&nbsp;Rana El Nahas,&nbsp;Ghalia Missous,&nbsp;Susanna Bodoy,&nbsp;Abbirami Sathappan,&nbsp;Mohammad Ameen Al-Aghbar,&nbsp;Clara Mayayo,&nbsp;Montse Olivé,&nbsp;Silvia Busquets-Rius,&nbsp;David Sebastián,&nbsp;Antonio Zorzano,&nbsp;Manuel Palacin,&nbsp;Nicholas van Panhuys,&nbsp;Virginia Nunes\",\"doi\":\"10.1002/jcsm.13847\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>The neutral amino acid transporter <i>SLC7A8</i> (LAT2) has been described as a key regulator of metabolic adaptation. LAT2 mutations in human populations have been linked to the early onset of age-related hearing loss and cataract growth. As LAT2 was previously found to be highly expressed in skeletal muscle, here we characterised its role in the regulation of <i>skeletal muscle</i> amino acid flux and metabolic adaptation to fasting.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Wild-type (WT) and LAT2 knock-out (LAT2KO) mice were exposed to short- and long-periods of fasting (16 and 48 h). The impact of the absence of LAT2 on amino acid content, gene expression, proteolysis activity, muscle tone, and histology was measured. To characterise the impact on muscle degradation, we tested LAT2 KO mice in cancer-associated cachexia, streptozocin-induced Type-1 diabetes, and ageing models.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>LAT2KO mice experienced a notable reduction in body weight during fasting (WT:14% and LAT2KO:18%, <i>p</i> = 0.02), with a greater reduction in fat mass (0.5-fold, <i>p</i> = 0.013) and a higher relative retention of muscle mass (1.3-fold, <i>p</i> = 0.0003) compared with WT. The absence of LAT2 led to increased intramuscular glutamine (Gln) accumulation (6.3-fold, <i>p</i> &lt; 0.0001), accompanied by a reduction in skeletal muscle proteolysis during fasting (0.61-fold, <i>p</i> = 0.0004) primarily due to decreased proteasomal and autophagic activity (0.45-fold, <i>p</i> = 0.016 and 0.7-fold, <i>p</i> = 0.002, respectively). Ex vivo incubation of LAT2KO muscle with rapamycin recovered proteolysis function, demonstrating a mTORC1-dependent pathway. Decreased proteolysis in LAT2KO animals was associated with increased mTORC1 translocation to the lysosome (mTORC1-Lamp1 colocalization in fasted LAT2KO muscles was 1.23-fold, <i>p</i> &lt; 0.0001). Of the three muscle loss models tested, differences were observed only during ageing. Young LAT2KO mice (3 M) exhibited muscle tone and MurF1 expression levels comparable to those of older WT mice (12 M) (0.44-fold, <i>p</i> = 0.02 and 0.48-fold, <i>p</i> = 0.04, respectively).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>LAT2 has a critical role in regulating Gln efflux from skeletal muscle. The absence of LAT2 led to elevated intracellular Gln levels, impairing muscle proteolysis by inducing mTORC1 recruitment to the lysosome. Further, chronic Gln accumulation and decreased proteolysis were found to induce the early onset of an age-related muscle phenotype.</p>\\n </section>\\n </div>\",\"PeriodicalId\":48911,\"journal\":{\"name\":\"Journal of Cachexia Sarcopenia and Muscle\",\"volume\":\"16 3\",\"pages\":\"\"},\"PeriodicalIF\":9.1000,\"publicationDate\":\"2025-06-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jcsm.13847\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cachexia Sarcopenia and Muscle\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jcsm.13847\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GERIATRICS & GERONTOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cachexia Sarcopenia and Muscle","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jcsm.13847","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

中性氨基酸转运体SLC7A8 (LAT2)被认为是代谢适应的关键调节因子。人群中的LAT2突变与年龄相关性听力损失和白内障生长的早期发病有关。由于先前发现LAT2在骨骼肌中高度表达,因此我们在这里描述了它在骨骼肌氨基酸通量调节和对禁食的代谢适应中的作用。方法将野生型(WT)和LAT2敲除型(LAT2KO)小鼠暴露于短时间和长时间禁食(16和48 h)。测定了LAT2缺失对氨基酸含量、基因表达、蛋白水解活性、肌张力和组织学的影响。为了描述对肌肉退化的影响,我们在癌症相关恶病质、链脲佐菌素诱导的1型糖尿病和衰老模型中对LAT2 KO小鼠进行了测试。结果:与WT相比,LAT2KO小鼠在禁食期间体重显著减少(WT:14%, LAT2KO:18%, p = 0.02),脂肪量减少幅度更大(0.5倍,p = 0.013),肌肉质量相对保留量更高(1.3倍,p = 0.0003)。缺乏LAT2导致肌内谷氨酰胺(Gln)积累增加(6.3倍,p < 0.0001),并伴有禁食期间骨骼肌蛋白分解减少(0.61倍,p = 0.0001)。P = 0.0004),主要是由于蛋白酶体和自噬活性降低(分别为0.45倍,P = 0.016和0.7倍,P = 0.002)。LAT2KO肌肉与雷帕霉素的体外孵育恢复了蛋白质水解功能,证明了mtorc1依赖途径。LAT2KO动物的蛋白水解减少与mTORC1向溶酶体易位增加有关(禁食LAT2KO肌肉中mTORC1- lamp1共定位为1.23倍,p < 0.0001)。在测试的三种肌肉损失模型中,只有在衰老过程中才观察到差异。年轻LAT2KO小鼠(3 M)的肌肉张力和MurF1表达水平与老年WT小鼠(12 M)相当(分别为0.44倍,p = 0.02和0.48倍,p = 0.04)。结论LAT2在骨骼肌Gln外排调控中起重要作用。LAT2的缺失导致细胞内Gln水平升高,通过诱导mTORC1向溶酶体募集而损害肌肉蛋白水解。此外,发现慢性谷氨酰胺积累和蛋白质水解减少可诱导年龄相关肌肉表型的早期发作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting-Induced Proteolysis

Ablation of LAT2 Transporter Causes Intramuscular Glutamine Accumulation and Inhibition of Fasting-Induced Proteolysis

Background

The neutral amino acid transporter SLC7A8 (LAT2) has been described as a key regulator of metabolic adaptation. LAT2 mutations in human populations have been linked to the early onset of age-related hearing loss and cataract growth. As LAT2 was previously found to be highly expressed in skeletal muscle, here we characterised its role in the regulation of skeletal muscle amino acid flux and metabolic adaptation to fasting.

Methods

Wild-type (WT) and LAT2 knock-out (LAT2KO) mice were exposed to short- and long-periods of fasting (16 and 48 h). The impact of the absence of LAT2 on amino acid content, gene expression, proteolysis activity, muscle tone, and histology was measured. To characterise the impact on muscle degradation, we tested LAT2 KO mice in cancer-associated cachexia, streptozocin-induced Type-1 diabetes, and ageing models.

Results

LAT2KO mice experienced a notable reduction in body weight during fasting (WT:14% and LAT2KO:18%, p = 0.02), with a greater reduction in fat mass (0.5-fold, p = 0.013) and a higher relative retention of muscle mass (1.3-fold, p = 0.0003) compared with WT. The absence of LAT2 led to increased intramuscular glutamine (Gln) accumulation (6.3-fold, p < 0.0001), accompanied by a reduction in skeletal muscle proteolysis during fasting (0.61-fold, p = 0.0004) primarily due to decreased proteasomal and autophagic activity (0.45-fold, p = 0.016 and 0.7-fold, p = 0.002, respectively). Ex vivo incubation of LAT2KO muscle with rapamycin recovered proteolysis function, demonstrating a mTORC1-dependent pathway. Decreased proteolysis in LAT2KO animals was associated with increased mTORC1 translocation to the lysosome (mTORC1-Lamp1 colocalization in fasted LAT2KO muscles was 1.23-fold, p < 0.0001). Of the three muscle loss models tested, differences were observed only during ageing. Young LAT2KO mice (3 M) exhibited muscle tone and MurF1 expression levels comparable to those of older WT mice (12 M) (0.44-fold, p = 0.02 and 0.48-fold, p = 0.04, respectively).

Conclusion

LAT2 has a critical role in regulating Gln efflux from skeletal muscle. The absence of LAT2 led to elevated intracellular Gln levels, impairing muscle proteolysis by inducing mTORC1 recruitment to the lysosome. Further, chronic Gln accumulation and decreased proteolysis were found to induce the early onset of an age-related muscle phenotype.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Cachexia Sarcopenia and Muscle
Journal of Cachexia Sarcopenia and Muscle MEDICINE, GENERAL & INTERNAL-
CiteScore
13.30
自引率
12.40%
发文量
234
审稿时长
16 weeks
期刊介绍: The Journal of Cachexia, Sarcopenia and Muscle is a peer-reviewed international journal dedicated to publishing materials related to cachexia and sarcopenia, as well as body composition and its physiological and pathophysiological changes across the lifespan and in response to various illnesses from all fields of life sciences. The journal aims to provide a reliable resource for professionals interested in related research or involved in the clinical care of affected patients, such as those suffering from AIDS, cancer, chronic heart failure, chronic lung disease, liver cirrhosis, chronic kidney failure, rheumatoid arthritis, or sepsis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信